Several pharmaceutical drugs, including sodium-glucose cotransporter-2 (SGLT2) inhibitors, biguanides, glitazones, and α-glucosidase inhibitors, are widely used to control insulin sensitivity and reduce blood glucose in T2D patients [6,7]. Here, SLC5A2 is linked to type 2 diabetes mellitus.